Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Laila Rashidi

Colon & Rectal Surgery Tacoma, WA Medical Doctor

NPI 1073839965 CMS profile 2788785

3124 S 19Th St Ste C220, Tacoma, WA 98405

Open in the dashboard

General payments

$805,377

851 records reported · program years 2019–2025

Research payments

$250

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Laila Rashidi of Tacoma, WA is reported in the CMS Open Payments database as having received $805,377 across 851 general payments and $250 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $206,234 185
2024 General $160,764 162
2024 Research $250 1
2023 General $140,407 154
2022 General $139,932 147
2021 General $77,047 83
2020 General $52,677 57
2019 General $28,316 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Laila Rashidi
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Laila Rashidi were reported at $206,234. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Laila Rashidi Colon & Rectal Surgery median Middle half National median
2019 $28,316 $443 $125–$2,179 $163
2020 $52,677 $167 $53–$931 $114
2021 $77,047 $207 $72–$1,272 $132
2022 $139,932 $341 $111–$1,587 $149
2023 $140,407 $322 $115–$1,420 $160
2024 $160,764 $328 $112–$1,354 $164
2025 $206,234 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $796,852 819 payments
  2. Histosonics, Inc. $3,514 2 payments
  3. Medical Device Business Services, Inc. $1,755 2 payments
  4. Ethicon Inc. $917 3 payments
  5. Allergan Inc. $607 5 payments
  6. Baxter Healthcare $311 2 payments
  7. Axonics Modulation Technologies, Inc. $271 3 payments
  8. CONMED Corporation $251 3 payments
  9. TELA Bio, Inc. $173 1 payment
  10. Hologic, LLC $149 1 payment
  11. Other $578 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $447,863 151 payments
  2. Education $242,948 107 payments
  3. Travel and Lodging $75,899 277 payments
  4. Food and Beverage $32,987 303 payments
  5. Consulting Fee $5,540 5 payments
  6. Gift $141 8 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $697,127 777 payments
  2. DA VINCI SP $98,225 41 payments
  3. DAVINCI XI $1,500 1 payment
  4. STRATTICE $490 2 payments
  5. Axonics $271 3 payments
  6. AIRSEAL $251 3 payments
  7. OviTex 2S $173 1 payment
  8. TISSEEL $164 1 payment
  9. CoolSeal Generator $149 1 payment
  10. SPY-PHI SYSTEM $146 1 payment
  11. Other $667 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Endolumik, Inc. $250 1 payment

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$68,551

Medicare's payments for the services billed

Medicare patients

122

Average age 74

Services billed

266

71 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Cancer 57%
Arthritis 45%
Chronic kidney disease 32%
Diabetes 28%
Ischemic heart disease 25%
Depression 25%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

852 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record